Innoviva, Inc.

INVA • NASDAQ • Stock Fundamentals

Innoviva, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Pavel Raifeld, with a market cap of $1.7B.

Market Cap$1.7B

Employees112.0

CEOPavel Raifeld

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Innoviva, Inc.

Innoviva, Inc. (INVA) has a market capitalization of $1.7B and trades on NASDAQ.

Innoviva, Inc. has approximately 112 employees.